CHA Vaccine Research Institute — Investor Relations & Filings
CHA Vaccine Research Institute is a research-oriented biotechnology company focused on developing vaccines and immunotherapeutics for the prevention and treatment of infectious diseases. The company's core strategy involves leveraging proprietary adjuvant platforms, such as L-pampo and L-pampo, which are based on Toll-like receptor (TLR) ligands, to enhance vaccine efficacy. Its development pipeline includes a third-generation prophylactic vaccine and a therapeutic vaccine for Hepatitis B (HBV), a recombinant vaccine for herpes zoster (shingles), and an improved influenza vaccine. In addition to its vaccine portfolio, the institute is developing immunotherapeutic proteins like recombinant Mannose-Binding Lectin (MBL) for broad-spectrum pathogen suppression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주권관련사채권의취득결정 | 2026-05-04 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-05-04 | Korean | |
| 임시주주총회결과 | 2026-04-30 | Korean | |
| 상호변경안내 | 2026-04-30 | Korean | |
| 최대주주변경 | 2026-04-30 | Korean | |
| 최대주주변경을수반하는주식담보제공계약체결 | 2026-04-30 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40839755 | 주권관련사채권의취득결정 | 2026-05-04 | Korean | ||
| 40762968 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-05-04 | Korean | ||
| 39078513 | 임시주주총회결과 | 2026-04-30 | Korean | ||
| 39078496 | 상호변경안내 | 2026-04-30 | Korean | ||
| 39078397 | 최대주주변경 | 2026-04-30 | Korean | ||
| 39078386 | 최대주주변경을수반하는주식담보제공계약체결 | 2026-04-30 | Korean | ||
| 39078375 | 대표이사변경 | 2026-04-30 | Korean | ||
| 34568256 | [기재정정]주주총회소집결의 | 2026-04-15 | Korean | ||
| 34568247 | 주주총회소집공고 | 2026-04-15 | Korean | ||
| 34568209 | 의결권대리행사권유참고서류 | 2026-04-15 | Korean | ||
| 33983552 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-10 | Korean | ||
| 33129769 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33046986 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-03-26 | Korean | ||
| 33038964 | 주식등의대량보유상황보고서(약식) | 2026-03-25 | Korean | ||
| 33038396 | 정기주주총회결과 | 2026-03-25 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
CHA Vaccine Research Institute via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17440/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17440 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17440 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17440 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17440}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHA Vaccine Research Institute (id: 17440)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.